← Back to Screener
Centene Corporation (CNC)
Price$62.33
Value ScoreB
Growth ScoreB
Momentum ScoreB
Favorite Metrics
Price vs S&P 500 (26W)50.51%
Price vs S&P 500 (4W)11.39%
VGM Score71.13
Market Capitalization$30.78B
All Metrics
P/CF (Annual)6.22x
Book Value / Share (Quarterly)$43.39
P/TBV (Annual)1.31x
Revenue Growth (3Y)10.45%
Cash Flow / Share (Quarterly)$14.13
Price vs S&P 500 (YTD)43.31%
Gross Margin (TTM)7.18%
Net Profit Margin (TTM)-3.25%
EPS (TTM)$-13.14
10-Day Avg Trading Volume4.50M
EPS Excl Extra (TTM)$-13.14
Revenue Growth (5Y)24.47%
EPS (Annual)$-13.54
ROI (Annual)-17.88%
Gross Margin (Annual)7.12%
Net Profit Margin (5Y Avg)0.45%
Cash / Share (Quarterly)$48.08
Revenue Growth QoQ (YoY)7.13%
ROA (Last FY)-8.70%
Revenue Growth TTM (YoY)17.02%
EBITD / Share (TTM)$-12.25
ROE (5Y Avg)-0.09%
Operating Margin (TTM)-3.68%
Cash Flow / Share (Annual)$8.51
P/B Ratio1.44x
P/B Ratio (Quarterly)0.75x
Net Income / Employee (Annual)$-109,300
EV / Revenue (TTM)0.13x
Net Interest Coverage (TTM)-8.92x
ROA (TTM)-7.90%
EPS Growth QoQ (YoY)18.16%
EV / EBITDA (TTM)8.16x
EPS Incl Extra (Annual)$-13.54
Current Ratio (Annual)1.10x
Quick Ratio (Quarterly)1.12x
3-Month Avg Trading Volume6.34M
52-Week Price Return13.66%
EV / Free Cash Flow (Annual)6.19x
Revenue / Employee (TTM)$3,242,200
Tangible BV / Share (Quarterly)$34.56
P/S Ratio (Annual)0.16x
Asset Turnover (Annual)2.54x
52-Week High$63.50
Operating Margin (5Y Avg)0.50%
EPS Excl Extra (Annual)$-13.54
CapEx CAGR (5Y)-2.47%
Tangible BV CAGR (5Y)-2.37%
26-Week Price Return58.44%
Quick Ratio (Annual)1.10x
13-Week Price Return44.05%
Total Debt / Equity (Annual)0.87x
Current Ratio (Quarterly)1.12x
Enterprise Value$25.89B
Revenue / Share Growth (5Y)12.65%
Asset Turnover (TTM)2.43x
Book Value / Share Growth (5Y)-1.77%
Revenue / Employee (Annual)$3,187,800
Pretax Margin (Annual)-3.45%
Cash / Share (Annual)$41.32
3-Month Return Std Dev58.93%
Gross Margin (5Y Avg)10.29%
Net Income / Employee (TTM)$-105,500
EBITDA Interim CAGR (5Y)11.22%
ROE (Last FY)-33.47%
Net Interest Coverage (Annual)-8.49x
EPS Basic Excl Extra (Annual)$-13.54
P/FCF (TTM)4.41x
Receivables Turnover (TTM)9.46x
EV / Free Cash Flow (TTM)3.71x
Total Debt / Equity (Quarterly)0.76x
EPS Incl Extra (TTM)$-13.14
Receivables Turnover (Annual)10.30x
ROI (TTM)-16.25%
P/S Ratio (TTM)0.16x
Pretax Margin (5Y Avg)0.86%
Revenue / Share (Annual)$394.99
Tangible BV / Share (Annual)$31.36
Forward P/E17.89x
Free OCF CAGR (5Y)-2.03%
Price vs S&P 500 (52W)-10.71%
Year-to-Date Return51.47%
5-Day Price Return0.53%
EPS Normalized (Annual)$-13.54
ROA (5Y Avg)0.36%
Net Profit Margin (Annual)-3.43%
Month-to-Date Return4.58%
Cash Flow / Share (TTM)$6.92
EBITD / Share (Annual)$-12.87
Operating Margin (Annual)-3.91%
LT Debt / Equity (Annual)0.87x
P/CF (TTM)3.94x
ROI (5Y Avg)0.29%
LT Debt / Equity (Quarterly)0.76x
EPS Basic Excl Extra (TTM)$-13.14
P/TBV (Quarterly)0.94x
P/B Ratio (Annual)1.01x
Pretax Margin (TTM)-3.22%
Book Value / Share (Annual)$40.57
Price vs S&P 500 (13W)35.79%
Net Margin Growth (5Y)-10.04%
Beta1.07x
P/FCF (Annual)7.36x
Revenue / Share (TTM)$399.73
ROE (TTM)-28.72%
52-Week Low$25.08
vGradeB
gGradeB
mGradeB
vgmGradeB
Show chart for
Earnings Surprise History
Q1 263.37est. 2.15
Analyst Recommendations
Mar 2026
Apr 2026
May 2026
Jun 2026
3.35
3.35
3.50
3.54
Industry Peers — Hospital & Medical Insurance(9)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
CNCCentene Corporation | B | B | B | $62.33 |
| UNHUNITEDHEALTH GROUP INCORPORATED (Delaware) | D | D | A | $399.47 |
| ELVElevance Health, Inc. | D | D | A | $415.53 |
| CIThe Cigna Group | C | C | C | $289.48 |
| HUMHumana Inc. | D | D | A | $350.08 |
| MOHMolina Healthcare, Inc. | D | D | B | $190.86 |
| OSCROscar Health, Inc. | B | A | A | $24.51 |
| ALHCAlignment Healthcare, Inc. Common Stock | D | A | F | $15.37 |
| CLOVClover Health Investments, Corp | D | A | A | $3.83 |
| TRUPTrupanion, Inc. | D | A | F | $22.00 |
About
Centene Corporation is a managed care organization serving 22 million members through government-sponsored health plans, with revenue diversified across Medicaid (approximately 60% of membership), individual exchange plans (20%), Medicare, and military contracts. The company also provides Medicare Part D pharmaceutical coverage. As a leading platform in government-sponsored healthcare, Centene benefits from stable government reimbursement and recurring membership revenue.